These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22275241)

  • 1. Eliminating the six N-terminal amino acids of the caspase 3 large subunit improved production of a biologically active IL2-Caspase3 chimeric protein.
    Glantz Y; Sabag O; Lichtenstein M; Grodzovski I; Lorberboum-Galski H
    Biotechnol Prog; 2012; 28(2):573-80. PubMed ID: 22275241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitis.
    Irony-Tur-Sinai M; Lichtenstein M; Brenner T; Lorberboum-Galski H
    Int Immunopharmacol; 2009 Sep; 9(10):1236-43. PubMed ID: 19631295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
    Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
    Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitis.
    Sagiv Y; Kaminitz A; Lorberboum-Galski H; Askenasy N; Yarkoni S
    Ann N Y Acad Sci; 2009 Sep; 1173():791-7. PubMed ID: 19758230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes.
    Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H
    Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fusion IL2-B7.1(IgV+C) and effects on T lymphocytes.
    Kong L; Li Y; Yang Y; Li K
    Biochem Cell Biol; 2007 Dec; 85(6):685-95. PubMed ID: 18059527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
    Potala S; Verma RS
    J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of a chimeric gene containing poly-arginine as the protein transduction domain and its killing activity against HER2 positive gastric cancer SGC-7901 cells].
    Zhao ZN; Wang T; Ren JL; Zhang R; Zhao J; Wen WH; Jia LT; Yang AG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):735-7. PubMed ID: 20619096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel design of targeted endocrine and cytokine therapy for breast cancer.
    Zhang G; Li W; Holle L; Chen N; Chen WY
    Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented antitumor activity of a secondary lymphoid-tissue chemokine (SLC)-interleukin (IL) 2 fusion protein in mouse.
    Nakahara K; Sakata T
    J Gene Med; 2003 Jun; 5(6):463-71. PubMed ID: 12797111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
    Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and AP1.
    Walker PR; Kwast-Welfeld J; Gourdeau H; Leblanc J; Neugebauer W; Sikorska M
    Exp Cell Res; 1993 Jul; 207(1):142-51. PubMed ID: 8319766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
    Kunzendorf U; Pohl T; Bulfone-Paus S; Krause H; Notter M; Onu A; Walz G; Diamantstein T
    J Clin Invest; 1996 Mar; 97(5):1204-10. PubMed ID: 8636431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Design and expression of a diphtheria toxin hybrid protein and human interleukin-2 gene in Escherichia coli].
    Shemiakin IG; Anisimova VA; Mitrofanova GN
    Mol Biol (Mosk); 1992; 26(5):1088-98. PubMed ID: 1470175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective targeting of activated T cells in chronic intestinal inflammation.
    Weigmann B; Neurath MF
    Gut; 2009 Jun; 58(6):747-8. PubMed ID: 19433594
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-2-granzyme A chimeric protein overcomes multidrug resistance (MDR) through a caspase 3-independent apoptotic pathway.
    Grodzovski I; Lichtenstein M; Galski H; Lorberboum-Galski H
    Int J Cancer; 2011 Apr; 128(8):1966-80. PubMed ID: 20568105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.